Your browser doesn't support javascript.
loading
Vaccine-mediated protection against Merbecovirus and Sarbecovirus challenge in mice.
Martinez, David R; Schäfer, Alexandra; Gavitt, Tyler D; Mallory, Michael L; Lee, Esther; Catanzaro, Nicholas J; Chen, Haiyan; Gully, Kendra; Scobey, Trevor; Korategere, Pooja; Brown, Alecia; Smith, Lena; Parks, Robert; Barr, Maggie; Newman, Amanda; Bowman, Cindy; Powers, John M; Soderblom, Erik J; Mansouri, Katayoun; Edwards, Robert J; Baric, Ralph S; Haynes, Barton F; Saunders, Kevin O.
Affiliation
  • Martinez DR; Department of Immunobiology, Yale School of Medicine, New Haven, CT 06510, USA; Yale Center for Infection and Immunity, Yale School of Medicine, New Haven, CT 06510, USA. Electronic address: david.martinez@yale.edu.
  • Schäfer A; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
  • Gavitt TD; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA.
  • Mallory ML; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
  • Lee E; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA.
  • Catanzaro NJ; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
  • Chen H; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA.
  • Gully K; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
  • Scobey T; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
  • Korategere P; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA.
  • Brown A; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA.
  • Smith L; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA.
  • Parks R; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA.
  • Barr M; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA.
  • Newman A; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA.
  • Bowman C; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA.
  • Powers JM; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
  • Soderblom EJ; Proteomics and Metabolomics Core Facility, Duke University School of Medicine, Durham, NC 27710, USA.
  • Mansouri K; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA.
  • Edwards RJ; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA.
  • Baric RS; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. Electronic address: rbaric@email.unc.edu.
  • Haynes BF; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA. Electronic address: barton.haynes@duke.edu.
  • Saunders KO; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA. Electronic address: kevin.saunders@duke.edu.
Cell Rep ; 42(10): 113248, 2023 10 31.
Article in En | MEDLINE | ID: mdl-37858337

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Severe acute respiratory syndrome-related coronavirus / Middle East Respiratory Syndrome Coronavirus Limits: Animals / Humans Language: En Journal: Cell Rep Year: 2023 Document type: Article Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Severe acute respiratory syndrome-related coronavirus / Middle East Respiratory Syndrome Coronavirus Limits: Animals / Humans Language: En Journal: Cell Rep Year: 2023 Document type: Article Country of publication: United States